Abstract
764P Tislelizumab (Anti-PD-1) combined with definitive chemoradiotherapy in recurrent and/or metastatic cervical cancer (PILOT-2020-511): A single-arm, phase II trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have